Speaking at a WIRED event Tuesday, Moderna CEO Stéphane Bancel said he was “encouraged” by the company’s dialogue with the FDA—but acknowledged recent setbacks.

If you're not over 65 or have certain risk factors, it might be hard to get one but not necessarily impossible. Here's what to know about the confusing and fast-changing rules for getting the shot.

LECOM Health, which partners with the Erie County Department of Health to provide vaccines, received its first shipment in early September.

Moderna, Inc. (NASDAQ:MRNA) today announced that five abstracts on its investigational mRNA therapeutics have been accepted for presentation at the 2025 International Congress of Inborn Errors of Metabolism (ICIEM),

The Food and Drug Administration (FDA) has approved the 2025-2026 formulations of Moderna’s COVID-19 vaccines Spikevax ® and mNexspike ®. The updated mRNA vaccines target the LP.8.1 variant of SARS-CoV-2, which was selected as the preferred strain at the FDA’s Vaccines and Related Biological Products Advisory Committee meeting in May 2025.

A little less than a year after targeting Moderna in an mRNA vaccine patent lawsuit, GSK is widening the scope of its litigation by throwing its rival’s next-generation COVID-19 shot into the fold. | In an amended complaint filed Thursday in Delaware federal court,

CVS will no longer require a prescription for the COVID-19 vaccine in Kentucky. But that doesn't mean everyone is eligible to get one.

As HHS Secretary Robert F. Kennedy Jr. continues to fend off criticism of his leadership and decisions at the agency, if he were to leave the post, Gilead Sciences (NASDAQ:GILD), Moderna (NASDAQ:MRNA),